| 1 |
Adamczyk M, PeczekŁ, Rudnicki C, et al. The clinical significance of gastropanel in diagnostics of Helicobacter pylori eradication efficiency in patients with dyspepsia with correlation of family history of gastric cancer[J]. Pol Merkur Lekarski,2013,35(207):141-147.
|
| 2 |
刘文忠，萧树东. 幽门螺杆菌新国际共识解读[J]. 胃肠病学,2012,17(1):1-4.
|
| 3 |
Suzuki H, Nishizawa T, Hibi T. Can Helicobacter pylori-associated dyspepsia be categorized as functional dyspepsia?[J]. J Gastroenterol Hepatol,2011,26(3):42-45.
|
| 4 |
Jafarzadeh A, Nemati M, Rezayati MT, et al. Higher circulating levels of anti-phosphatidylserine antibody in peptic ulcer patients infected with CagA-positive strains of Helicobacter pylori[J]. Clin Lab,2013,59(9-10):977-984.
|
| 5 |
Liu J, He C, Chen M, et al. Association of presence/absence and on/off patterns of Helicobacter pylori oipA gene with peptic ulcer disease and gastric cancer risks:a meta-analysis[J]. BMC Infect Dis,2013,13:555.
|
| 6 |
黄叶妮，刘丽. 幽门螺杆菌感染的治疗进展[J]. 现代生物医学进展,2012,12(17):3398-3399.
|
| 7 |
成积儒，蔡永林，黄德旺, 等. 336例上消化道疾病患者的幽门螺杆菌抗体谱检测结果分析[J]. 广西医学,2009,31(6):807-808.
|
| 8 |
Futagami S, Shimpuku M, Yin Y, et al. Pathophysiology of functional dyspepsia[J]. J Nihon Med Sch,2011,78(5):280-285.
|
| 9 |
Lansdorp-Vogelaar I, Sharp L. Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention[J]. Best Pract Res Clin Gastroenterol,2013,27(6):933-947.
|
| 10 |
Miwa H, Watari J, Fukui H, et al. Current understanding of pathogenesis of functional dyspepsia[J]. J Gastroenterol Hepatol,2011,26(3):53-60.
|
| 11 |
Suzuki H, Matsuzaki J, Hibi T. What is the difference between Helicobacter pylori-associated dyspepsia and functional dyspepsia?[J]. J Neurogastroenterol Motil,2011,17(2):124-130.
|
| 12 |
Saito Y, Suzuki H, Tsugawa H, et al. Dysfunctional gastric emptying with down-regulation of muscle-specific microRNAs in Helicobacter pylori-infected mice[J]. Gastroenterology,2011,140(1):189-198.
|
| 13 |
Takeuchi K, Ohishi M, Ota S, et al. Metabolic profiling to identify potential serum biomarkers for gastric ulceration induced by nonsteroid anti-inflammatory drugs[J]. J Proteome Res,2013,12(3):1399-1407.
|
| 14 |
于中麟. 慢性胃炎的内镜分型分级标准及治疗的试行意见[J]. 中华消化内镜杂志,2004,21(2):4-5.
|
| 15 |
Kato M, Ono S, Yoshida T, et al. Significance of H. pylori eradication in treatment and prevention for low-dose aspirin induced gastric ulcer of elderly[J]. NihonRinsho,2010,68(11):2089-2095.
|
| 16 |
Naqano Y, Matsui H, Tamura M, et al. NSAIDs and acidic environment induce gastric mucosal cellular mitochondrial dysfunction[J]. Digestion,2012,85(2):131-135.
|
| 17 |
朱玉群，杨绍徐. 幽门螺旋菌感染与胃癌的相关性研究[J]. 首都医科大学学报,2009,3(17):49-50.
|
| 18 |
Boike JR, Kao R, Meyer D, et al. Does concomitant use of paracetamol potentiate the gastroduodenal mucosal injury associated with aspirin? A prospective, randomised, pilot study[J]. Aliment Pharmacol Ther,2012,36(4):391-397.
|
| 19 |
朱敏，袁昌琼，杨慧英, 等. 胃肠外疾病患者幽门螺旋杆菌感染治疗探析[J]. 河北医学,2013,19(12):1795-1797.
|
| 20 |
Seo PJ, Kim N, Kim JH, et al. Comparison of indomethacin, diclofenac and aspirin-induced gastric damage according to age in rats[J]. Gut Liver,2012,6(2):210-217.
|
| 21 |
Tamural I, Fujita T, Tsumura H, et al. Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease[J]. Inter Med,2010,49(23):2537-2545.
|
| 22 |
Ryter SW, Cloonan SM, Choi AM. Autophagy: a critical regulator of cellular metabolism and homeostasis[J]. Mol Cells,2013,36(1):7-16.
|
| 23 |
Chen HC, Fong TH, Lee AW, et al. Autophagy is activated in injured neurons and inhibited by methylprednisolone after experimental spinal cord injury[J]. J Spine,2012,37:470-475.
|
| 24 |
He LQ, Lu JH, Yue ZY. Autophagy in ageing and ageing-associated diseases[J]. Acta Pharmacol Sin,2013,34(5):605-611.
|
| 25 |
Naqano Y, Matsui H, Tamura M, et al. NSAIDs and acidic environment induce gastric mucosal cellular mitochondrial dysfunction[J]. Digestion,2012,85(2):131-135.
|